Literature DB >> 20940014

Protective effects of novel single compound, Hirsutine on hypoxic neonatal rat cardiomyocytes.

Li Xin Wu1, Xian Feng Gu, Yi Chun Zhu, Yi Zhun Zhu.   

Abstract

Uncaria rhynchophylla is a traditional Chinese herb that has been applied in China for treatment of ailments of the cardiovascular system, but little is known about its active constituents and effect in cardiomyocytes. In present study, we investigated the cardioprotective effect of 0.1μΜ, 1μΜ and 10μΜ Hirsutine isolated from the methanolic extracts of Uncaria rhynchophylla by high performance liquid chromatography (HPLC) on neonatal rat cardiomyocytes treated with hypoxia to determine the mechanism underlying the protective effect with regard to cardiac anti-oxidant enzymes and apoptosis genes. Hirsutine significantly increased the viability of cardiomyocytes injured by hypoxia. Gene expression levels of proapoptotic genes (Bax, Fas and caspase-3) were significantly downregulated compared with the hypoxic control group (P<0.05), whereas the expression level of Bcl-2 was upregulated following Hirsutine treatment (P<0.05). Correspondingly, Hirsutine treatment increased Bcl-2 protein level and decreased Bax protein level. Assay investigating cardiac anti-oxidant enzymes provided further evidence for the protective effect of Hirsutine, as indicated by the induction of the anti-oxidant enzymes superoxide dismutase. The results of present study suggest that the mechanism of action of Hirsutine in hypoxic neonatal rat cardiomyocytes may be related to its anti-oxidant and anti-apoptotic properties. This may open an avenue for developing novel candidate compounds with cardioprotectiveeffect from unique Chinese plant.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20940014     DOI: 10.1016/j.ejphar.2010.09.057

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Targeting the ataxia telangiectasia mutated pathway for effective therapy against hirsutine-resistant breast cancer cells.

Authors:  Chenghua Lou; Satoru Yokoyama; Sherif Abdelhamed; Ikuo Saiki; Yoshihiro Hayakawa
Journal:  Oncol Lett       Date:  2016-05-11       Impact factor: 2.967

2.  Shexiang Tongxin Dropping Pill () Protects against Na2S2O4-Induced Hypoxia-Reoxygenation Injury in H9c2 Cells.

Authors:  Shan Lin; Jiu-Mao Lin; Ling Zhang; Da-Xin Chen; Fei Xiao; Hong-Wei Chen; You-Qin Chen; Yu-Ling Zhu; Jian-Feng Chu; Jun Peng
Journal:  Chin J Integr Med       Date:  2018-04-04       Impact factor: 1.978

3.  The novel analogue of hirsutine as an anti-hypertension and vasodilatary agent both in vitro and in vivo.

Authors:  Kai Zhu; Su-Na Yang; Fen-Fen Ma; Xian-Feng Gu; Yi-Chun Zhu; Yi-Zhun Zhu
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

4.  Hirsutine, an Indole Alkaloid of Uncaria rhynchophylla, Inhibits Late Step in Dengue Virus Lifecycle.

Authors:  Takayuki Hishiki; Fumihiro Kato; Shigeru Tajima; Kazufumi Toume; Masahito Umezaki; Tomohiko Takasaki; Tomoyuki Miura
Journal:  Front Microbiol       Date:  2017-08-30       Impact factor: 5.640

5.  Hirsutine induces mPTP-dependent apoptosis through ROCK1/PTEN/PI3K/GSK3β pathway in human lung cancer cells.

Authors:  Rong Zhang; Guobing Li; Qian Zhang; Qin Tang; Jingbin Huang; Changpeng Hu; Yali Liu; Qing Wang; Wuyi Liu; Ning Gao; Shiwen Zhou
Journal:  Cell Death Dis       Date:  2018-05-22       Impact factor: 8.469

6.  Inhibitory effect and mechanism of action (MOA) of hirsutine on the proliferation of T-cell leukemia Jurkat clone E6-1 cells.

Authors:  Jie Meng; Rui Su; Luping Wang; Bo Yuan; Ling Li
Journal:  PeerJ       Date:  2021-02-02       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.